Portfolio & Strategic Planning

A global biopharmaceutical company on a mission to Solve On, Incyte follows science to find solutions for patients with unmet medical needs. Through the discovery, development, and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Hematology, Oncology and Inflammation and Autoimmunity

Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe, and Asia.

The Director, Market Insights & Analytics, U.S. Portfolio & Launch Readiness supports U.S. market insights, forecast transition, strategic planning, and launch-readiness analytics for assets approaching commercialization. The role serves as the U.S. commercial bridge between global early-stage forecasting and U.S. launch planning, ensuring assets within approximately two years of expected U.S. launch have clear, pressure-tested assumptions, planning timelines, market context, analytics requirements, and source-of-truth outputs.

This role partners closely with Global Forecasting, U.S. Commercial, Market Insights & Forecasting, Commercial Analytics, Reporting & Decision Support, Finance, Market Access, Medical, Data/Technology, BIS, and other cross-functional stakeholders to translate global forecast inputs into U.S.

-specific commercial assumptions, strategic planning materials, launch-readiness reporting requirements, and executive-ready decision support.

The Director reports into Market Insights & Forecasting and has dotted-line accountability to Analytics & Decision Support for dashboard requirements, reporting automation, data structure, and analytical production standards. The role ensures near-launch assets are incorporated into U.S. strategic planning, forecast governance, executive reporting, and future-state commercial intelligence capabilities without duplicating early-stage global forecasting ownership.

This is an individual contributor role that leads through influence across global and U.S. stakeholders, with no direct people-management responsibility.

• Lead U.S. forecast transition and launch-readiness planning for assets approaching commercialization, with emphasis on products expected to enter U.S. commercial planning windows within approximately two years of launch.
• Partner with global forecasting teams to understand early-stage forecast assumptions, market models, epidemiology, patient flow, competitive context, evidence expectations, and key uncertainties.
• Translate global forecast inputs into U.S.
  
  -specific commercial planning assumptions, including market size, patient opportunity, treatment flow, adoption drivers, access considerations, competitive dynamics, launch timing, and scenario ranges.
• Support the Senior Director, Market Insights & Forecasting in developing U.S. forecast assumptions, strategic planning inputs, scenario framing, launch-readiness narratives, risk and opportunity assessments, and senior leadership materials.
• Coordinate U.S. strategic planning timelines, deliverables, assumption-gathering processes, cross-functional inputs, review meetings, and consolidated planning materials for near-launch assets.
• Develop and maintain structured handoff processes between global early-stage forecasting and U.S. commercial planning to ensure clear ownership, assumption traceability, documentation, and decision rights.
• Partner with the Director, Analytics & Decision Support to develop launch-readiness dashboards, planning trackers, forecast comparison views, assumption logs, milestone trackers, and source-of-truth reporting outputs.
• Partner with Data/Technology, BIS, Finance, and analytics stakeholders to define reporting requirements, support automation of recurring launch-readiness views, integrate planning inputs, and create scalable reporting structures for assets moving toward commercialization.
• Synthesize primary research, secondary data, competitive intelligence, global assumptions, market access inputs, Medical perspective, and U.S. commercial feedback into clear planning implications and recommended actions.
• Support executive-ready materials for strategic planning, launch planning, investment prioritization, forecast reviews, business updates, and cross-functional leadership discussions.
• Track key external and internal signals that may affect U.S. commercialization assumptions, including clinical readouts, regulatory milestones, guideline updates, competitive events, access dynamics,…